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Abstract
Objective—Children diagnosed with autism spectrum disorder (ASD) require substantial support 
to address not only core ASD symptoms, but also a range of co-occurring conditions. This study 
explores treatment and service use among children with ASD with and without intellectual 
disability (ID), and parents’ perception of unmet needs from these treatments.
Methods—Data come from a probability-based national sample of 2,077 children diagnosed with 
either ASD, ID, or both (ASD and ID). Weighted multivariate logistic regressions examined 
differences between diagnostic groups for current medication and service utilization with a sub-
analysis exploring differences among those with co-occurring psychiatric conditions. Additional 
modeling examined parents’ perception of unmet needs.
Results—Children diagnosed with ASD and ID were significantly more likely to be receiving 
current medication and services when compared to children with ID only or ASD only. Children 
with a co-occurring psychiatric diagnosis, from all 3 diagnostic groups, were more likely to be 
receiving a current medication, but not more likely to be receiving a current service when 
compared with children without a co-occurring psychiatric diagnosis. Children with ASD and a 
co-occurring psychiatric diagnosis were significantly more likely to have parents who reported 
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unmet needs when compared with parents of children with ASD without a co-occurring 
psychiatric diagnosis.
Conclusions—Children diagnosed with ASD and ID, especially those with a comorbid 
psychiatric condition, represent a vulnerable population with substantial rates of current service 
(98%) and medication (67%) usage, but despite these high rates, approximately 30% of parents 
report that their child’s developmental needs are still not being met by their current treatment and 
services.
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INTRODUCTION
Children diagnosed with autism spectrum disorder (ASD) are characterized by deficits in 
social communication and interaction, and the presence of stereotyped and repetitive 
behaviors.1 In addition to a primary ASD diagnosis, co-occurring conditions such as 
developmental, psychiatric, neurological, and other medical conditions are also common.2–4 
It is therefore unsurprising that children diagnosed with an ASD require substantial support 
to address not only the core symptoms of an ASD but the range of co-occurring conditions 
and symptoms as well. Previous research has indicated high rates of psychotropic 
medication use and service use, including school-based services, among children diagnosed 
with an ASD.5–8 However, only a limited number of studies have delineated how co-
occurring conditions, including common conditions such as intellectual disability (ID), are 
associated with service use. Given that treatments for children with ASD can translate into 
high costs for families, insurance providers, school districts, and society,9–13 it is also 
important to better understand the service needs, the patterns of service use, and the 
adequacy of existing services in meeting the manifold support and intervention needs among 
a diverse population of children with ASD. In particular, children diagnosed with ASD and 
ID have been noted to receive an ASD diagnosis earlier than those with ASD only,14 so 
these children may also receive earlier and different services and treatments than children 
without ID.15
Variations in how well the needs of children with ASD are being met, and the degree to 
which their parents are satisfied with the services they receive are poorly understood and 
may vary by the co-occurring diagnoses of the child. There are several reports of parental 
dissatisfaction with the diagnostic process for children with ASD,16–17 but little is known 
about parental satisfaction and perception of unmet needs regarding their child’s 
treatment.18–19 Previous research highlights parental concern about limitations in specialty 
medical care, including mental health care, and lack of a medical home among families 
raising children with an ASD.20–23 These studies, however, do not examine the presence of 
co-occurring psychiatric conditions, thereby overlooking the heterogeneous nature of 
children diagnosed with ASD.
This study attempts to address the current gaps in the literature by exploring treatment and 
service use among a nationally representative and clinically diverse population of children 
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diagnosed with ASD with and without co-occurring psychiatric conditions, with an 
additional investigation of parents’ perception of whether their child has unmet 
developmental needs. Children diagnosed with ID without ASD provide an appropriate 
statistical (and clinical) reference to children diagnosed with both ASD and ID, given the 
need for significant (and potentially) lifelong support needs for learning and behavioral 
challenges among children diagnosed with ID.24–26
It is hypothesized that service use and unmet needs would increase as the complexity of the 
conditions in need of treatment increased. Mainly, (1) children with ASD and ID would 
have higher rates of medication, service use, and unmet needs than children with ASD only 
or ID only, and given the potential for additional symptomatology unrelated to ASD 
requiring treatment, (2) children diagnosed with ASD and a co-occurring psychiatric 
condition would have higher rates of service and medication use, as well as greater rates of 




Data for the current study were retrieved from the 2011 Survey of Pathways to Diagnosis 
and Services (also known as “Pathways”), a follow-up study to the 2009–2010 National 
Survey of Children with Special Health Care Needs (NS-CSHCN), a cross-sectional 
random-digit-dial telephone survey (landlines and cell phones) of US households with at 
least one child aged 0 to 17 years at the time of interview with special health care needs. 
Pathways, conducted by the National Center for Health Statistics (NCHS), was a module of 
the State and Local Area Integrated Telephone Survey (SLAITS), and was sponsored by the 
National Institute of Mental Health (NIMH) of the National Institutes of Health (NIH) to 
collect information about the diagnostic experiences of children with special health care 
needs (CSHCN) aged 6 to 17 years old who were ever diagnosed with autism spectrum 
disorder (ASD), intellectual disability (ID), and/or developmental delay (DD). Additionally, 
Pathways was designed to provide information about the current clinical treatment, 
interventions, and educational services these children receive. The completion rate for the 
Pathways survey was 62%, which translates into a 16% response rate when incorporating 
the 26% response rate of the NS-CSHCN. Pathways shares the complex survey design of the 
NS-CSHCN, with clustering of children within households and stratification by state and 
sample type (landline or cell phone). More information about both Pathways and the NS-
CSHCN including the consent procedures can be found at http://www.cdc.gov/nchs/
slaits.htm. Verbal consent was obtained from a parent or guardian respondent at the time of 
the interview (hereafter referred to as the parent), with respondents being informed of their 
rights as survey participants. Only one child was sampled from a given household; if more 
than one child was eligible, one was randomly selected.
Sample
The study sample was restricted to CSHCN with a parent-reported diagnosis of ASD or ID 
(n=2,077), which included CSHCN diagnosed with ASD only (n=1,117), ASD and ID 
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(n=303), and ID only (n=657). Because children who were diagnosed with either ASD or ID 
are almost exclusively identified as CSHCN given the need for routine health and related 
services,27 hereafter we simply identify them as children with ASD or ID. Basic 
demographics by diagnostic classification appear in Table 1.
Measures
Diagnostic criteria—An initial screener question for the Pathways survey asked the 
parents to confirm whether “a doctor or other health care provider” had ever told them that 
the child had “autism, Asperger’s Disorder, pervasive developmental disorder, or other 
autism spectrum disorder”, “any developmental delay that affects [his/her] ability to learn,” 
or an “intellectual disability or mental retardation.” The parent was subsequently asked 
whether the diagnosis was current for each confirmed diagnosis. Parents were also asked 
whether their child has a current co-occurring psychiatric condition (“depression,” “anxiety 
problems,” “Attention-Deficit Disorder or Attention-Deficit/Hyperactivity Disorder 
(ADHD),” or “behavioral or conduct problems”). Data on the presence of selected 
neurodevelopmental conditions (“Down Syndrome,” “Cerebral Palsy,” “epilepsy or seizure 
disorder,” and “a head injury, concussion, or traumatic brain injury”) were obtained from the 
NS-CSHCN, because parent report of these diagnoses was not confirmed in Pathways.
Medication and service use—Parents were asked whether their child currently receives 
various medications and services on a regular basis. Medications were categorized as 
stimulants, antidepressants, antianxiety or mood stabilizers, antiseizure, antipsychotics, and 
sleep medications. School and community services included physical therapy, social skills 
training, occupational therapy, and speech or language therapy. Additional community 
services included behavioral intervention or modification services, sensory integration 
therapy, and cognitive based therapy.
Demographics—Child demographics included child’s age, gender, race, ethnicity, and 
current health insurance coverage status (and type if insured). Household characteristics 
included income level (recoded as a percentage of the federal poverty level28), educational 
attainment of the highest educated parent, and family structure (2 biological, adoptive or 
step parents compared to all other family types).
Unmet needs—The parent was asked whether in the past 12 months their child received 
“all the treatments and services necessary to meet [his/her] developmental needs” as well as 
“[saw] all the service providers needed to care for [his/her] developmental needs.” The 
child’s physical, social, and emotional growth and learning were provided as examples of 
child development, with unmet developmental needs being present when supports and care 
were not available or provided.
Statistical Analysis
All estimates were calculated using Stata 12.029 which accounted for the complex survey 
design. Statistical differences between ASD and ID groups on current treatment use are 
presented in Table 2. Corrected χ2 tests were used to explore whether a difference exists 
between the diagnostic groups, with post hoc logistic regressions comparing each diagnostic 
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groups to each other when applicable. Multivariate logistic regressions were run to 
determine if the use of medication, school-based services, and community-based services 
differed by diagnostic groups, adjusting for child and household characteristics, including 
child’s age, gender, race, ethnicity, current health insurance status and type, and the 
presence of co-occurring medical conditions, as well as the household’s federal poverty 
level, family structure and the highest level of education attained by a household member 
(adjusted odds ratios (AORs) are presented).
Additional multivariate logistic regressions compared service and treatment use based on the 
presence of co-occurring psychiatric conditions (depression, anxiety problems, ADHD and 
conduct or behavioral problems) for each diagnostic group. A final series of multivariate 
logistic regressions compared the views of parents of children with ASD regarding whether 
the developmental needs of their child were being met. All models were adjusted for child 
and household demographics and are presented as AORs.
RESULTS
Table 1 presents demographics estimates of the population subdivided by diagnosis. Overall, 
children with autism spectrum disorder (ASD) or intellectual disability (ID) were primarily 
male (72.2%), currently insured (97.6%), and living in households with a highly educated 
parent (73.8%) having attended some or more college. Children diagnosed with ASD and ID 
(80.5%) or with ASD only (82.6%) were more likely to be male than children with ID only 
(51.4%). Children diagnosed with ASD only were more likely to live in two-parent 
households and were younger than children with ID only.
Co-occurring psychiatric diagnoses were common (64.4%). Children diagnosed with ASD 
and ID (76.6%) and ASD only (67.8%) had higher rates than children with ID only (53.1%). 
Children with ID only were the least likely to have behavioral or conduct problems or 
anxiety problems. Children diagnosed with ASD and ID were the most likely to have 
behavioral or conduct problems.
Table 2 highlights the percentage of children currently receiving specific treatments and 
services, again subdivided by diagnosis. Children with both ASD and ID were the most 
likely to be receiving services for their condition when compared with children with ASD 
only (OR=9.85, 95% CI: 4.14–23.40, p<.001) or ID only (OR=6.67, 95% CI: 2.61–17.03, 
p<.001). They were also more likely to be receiving medication compared with children 
with ASD only (OR=1.81, 95% CI: 1.17–2.82, p<.01) or ID only (OR=2.40, 95% CI: 1.44–
4.03, p<.01). Children with ASD and ID were more likely to be receiving antidepressants, 
antipsychotics, and antianxiety or mood stabilizers when compared to children with ID only, 
and they were more likely to be receiving antiseizure medications, antidepressants and 
antianxiety or mood stabilizers than children with ASD only. Children diagnosed with ASD 
only were more likely to be receiving stimulants than children with ID only.
Children diagnosed with ASD and ID had the highest current use of school-based social 
skills training and speech language therapy, and the highest current use of community-based 
sensory integration services, cognitive behavioral services, and speech language therapy. 
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Children with ID only were less likely to be receiving behavioral modification services 
compared to children with both ASD and ID or children with ASD only.
Multivariate logistic regressions adjusting for child and household demographics revealed 
that children with both ASD and ID were receiving more intervention services than children 
in the other two diagnostic categories. More specifically, children with ASD and ID were 
more likely to be receiving current medication (AOR=2.54, 95% CI: 1.37–4.71, p<.01) and 
current services (AOR=7.73, 95% CI: 2.81–21.24, p<.001) than children with ID only. They 
were also more likely to be receiving current medication (AOR=2.08, 95% CI: 1.23–3.53, 
p<.01) and current services (AOR=8.87, 95% CI: 3.76–20.92, p<.001) than children with 
ASD only. Additionally, children diagnosed with ASD and ID were more likely to currently 
be receiving 2 or more classes of medication than children with ID only (AOR=2.18, 95% 
CI: 1.17–4.03, p<.05), and 2 or more current services than children with ID only 
(AOR=2.19, 95% CI: 1.09–4.39, p<.05) or ASD only (AOR=2.50, 95% CI: 1.29–4.83, p<.
01). Finally, children diagnosed with ASD and ID were more likely to be receiving services 
in the school and in the community concurrently when compared to children with ID only 
(AOR=2.32, 95% CI: 1.30–4.12, p<.01) or ASD only (AOR=1.89, 95% CI: 1.15–3.10, p<.
05).
The percentages of children receiving any current medication or service are displayed in 
Figure 1, which further divides the diagnostic groups into children with and without a 
current co-occurring psychiatric diagnosis of depression, anxiety problems, attention-deficit/
hyperactivity disorder (ADHD), or behavioral or conduct problems. Across diagnostic 
categories, children with a co-occurring psychiatric diagnosis were more likely to be 
receiving medication than children without a psychiatric diagnosis, after adjusting for child 
and household demographics. However, children with a co-occurring diagnosis were not 
more likely to be receiving current services within each diagnostic group. When examining 
all current diagnoses (including co-occurring psychiatric conditions and diagnostic 
classification), ID (AOR=1.75, 95% CI: 1.01–3.03, p<.05), anxiety problems (AOR=3.13, 
95% CI: 2.05–4.77, p<.001) and ADHD (AOR=4.83, 95% CI: 3.17–7.35, p<.001) were 
significantly associated with current medication use (Table 3). In contrast, current ASD 
(AOR=7.86, 95% CI: 2.78–22.24, p<.001) and current ID (AOR=9.22, 95% CI: 3.82–22.25, 
p<.001) diagnoses – but no psychiatric diagnoses – were significantly associated with 
service use.
Finally, multivariate logistic regressions examined parental views on whether their child’s 
developmental needs were being met among children diagnosed with ASD (Table 4). 
Children with an ASD and a co-occurring psychiatric diagnosis were significantly more 
likely to have unmet treatment and service needs (AOR=2.36, 95% CI: 1.46–3.81, p<.001) 
and provider needs (AOR=1.87, 95% CI: 1.11–3.13, p<.05) for their child’s development 
when compared with children with ASD without a co-occurring psychiatric diagnosis.
DISCUSSION
In this study, children with special health care needs who were diagnosed with either autism 
spectrum disorder (ASD), intellectual disability (ID), or both conditions had high rates of 
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medication and service use, with the highest rates found for children with combined ASD 
and ID diagnoses. Of the total sample, 52.6% of children were currently receiving at least 
one class of medication, whereas 66.9% of children diagnosed with both ASD and ID were 
receiving at least one class of medication. A similar finding was found for service use, with 
virtually all children diagnosed with an ASD and ID receiving at least one current service 
(97.7%), compared with 81.0% of children with ASD only and 86.3% of children with ID 
only. In adjusted models, these differences were significant; children with ASD and ID were 
more likely to be receiving current medication and services compared with children with 
ASD only and ID only. Among children diagnosed with ASD only, 66.8% were receiving 
specialized school-based intervention services compared with 93.4% of children diagnosed 
with ASD and ID. Community-based services were also common within this population, 
with 61.7% of children with ASD only receiving these services compared with 72.2% of 
children with ASD with ID. The combined rates among those children diagnosed with ASD, 
be they ASD and ID or ASD only, are similar to other studies of medication use and use of 
community-based services.30–32
Children diagnosed with ASD (with or without ID) who had a co-occurring psychiatric 
diagnosis were more likely to be receiving medication, a finding that is supported by 
previous research with a national registry of children with ASD.33 Medication use was 
related to the presence of a co-occurring psychiatric diagnosis, but not to the presence of 
ASD, with anxiety and ADHD being significant predictors of medication use. In contrast, 
psychiatric diagnoses were not associated with current service use; rather, service use was 
related to the child’s ASD or ID diagnosis. It is possible that this finding reflects the 
efficacious of medications for ADHD and anxiety, but not necessarily for ASD, where 
behavioral therapy may be more appropriate.34–35
Finally, children with ASD (with or without ID) and co-occurring psychiatric conditions, 
when compared to children with ASD and no psychiatric conditions, were more likely to 
have unmet developmental needs – both in terms of receiving all necessary treatment and 
services as well as in seeing all necessary providers. A previous national survey found that 
children diagnosed with ASD were more likely to have unmet needs when compared with 
children with other special health care needs,36 but the study did not evaluate the presence of 
co-occurring psychiatric conditions among children with ASD.
The high rate of unmet needs despite high service usage warrants a further investigation. 
There has been noted variability in the structure of community early intervention programs37 
and the availability of specialists38 which could factor into the quality of the services 
received. It is also possible that a parent’s perception of whether their child’s developmental 
needs are being met may be influenced by a parent’s belief of what services can and should 
accomplish for their child, and could be based on unrealistic expectations. Unfortunately, 
data were not available in this study to evaluate parental expectations nor the quality of 
services received.
Limitations
The current study uses a large probability based national sample of children with ASD, 
perhaps the largest available to date. The large sample size allows for subanalysis between 
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children with and without ID, as well as with or without a comorbid psychiatric condition. 
Despite these strengths, the study needs to be viewed in light of its limitations. Pathways 
was a cross-sectional parent-reported survey; thus it is not possible to determine the 
directionality of associations or the existence of causality. Although efforts were made to 
collect data regarding the most common psychiatric diagnoses, it is not possible to rule out 
unmeasured confounding for nonreported disorders and conditions that could increase a 
child’s use of medication or services. Moreover, estimates based on telephone surveys with 
low response rates may be unreliable due to selection biases resulting from sampling, 
nonresponse, lack of coverage of households without telephones, and respondent 
classification and reporting errors (due perhaps to a lack of clinical validation of conditions 
which parents believed their children to still have and the broad terminology of some 
conditions used in the survey). The impact of these potential biases on the results presented 
in the study is unknowable. Therefore, the representativeness of the estimates (which are 
limited to children aged 6 to 17) cannot be confirmed because biases may remain that are 
not related to known demographics. However, sample weights were adjusted to account for 
known demographic correlates of nonresponse and were calculated in accordance with best 
practices for sample surveys.
Implications
Given the multiple developmental, emotional, and behavioral issues that children with ASD 
and co-occurring psychiatric conditions have, it is perhaps unsurprising that these children 
have a higher proportion of unmet developmental needs, both with treatment and services 
(32.5%) and providers (24.8%). Psychiatric disorders, as well as the presence of ID, are 
prevalent among children diagnosed with an ASD; other studies have found rates as high as 
70%, with approximately 30% of children being diagnosed with ADHD and anxiety 
disorders.3 These estimates coincide with the overall prevalence of co-occurring psychiatric 
diagnoses found in the present study. These findings suggest that children with ASD and co-
occurring psychiatric diagnoses, as well as those with ID, who use the highest rates of 
services and treatments, represent a unique subpopulation that may be in need of further 
service and treatment options that address these children’s distinct behavioral and emotional 
challenges.39
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Prevalence of medication and service use, by presence of a co-occurring psychiatric 
diagnosis
Notes: ASD: autism spectrum disorder, ID: intellectual disability
* Indicates significant differences in prevalence estimates (p<.05) between children with and 
without psychiatric comorbidity for a given diagnosis
Co-occurring psychiatric diagnoses include ADHD, depression, anxiety problems, and 
conduct and behavioral problems
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Table 3



































ADHD: Attention-Deficit/Hyperactivity Disorder, AOR: adjusted odds ratio, CI: confidence interval
Odds ratios are adjusted by child and family demographics.
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